T2 Ribonuclease RNA Cleavage Conditions for Reproducible Sequence Mapping

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for enzymatic cleavage of RNA, such as those using RNase T1, RNase MCI, and Cusativin, suffer from non-specific cleavage and low reproducibility, leading to incomplete sequence coverage and low-confidence data, especially for longer RNA molecules.

Innovation Solution

Optimizing the pH conditions (6.5-9.5) and using ethylenediaminetetraacetic acid (EDTA) concentrations to enhance the site-specific cleavage of RNA polynucleotides with T2 family endoribonucleases like RNase MC1 and Cusativin, resulting in longer digestion products and improved sequence coverage.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If RNase T1, RNase MCI, or Cusativin are used for RNA cleavage, then RNA sequence mapping can be performed, but the cleavage is non-specific and reproducibility is low

Engineering Contradiction:
Improvereproducibility of oligonucleotide profilesVSAvoidsite-specific cleavage precision
Core Design Contradiction:
ReliabilityVSManufacturing precision

Solution Approach 1:

The patent optimizes pH conditions (pH 6.5-9.5) and buffer composition to enhance the site-specific cleavage specificity of T2 family endoribonucleases. By adjusting these chemical parameters, the enzyme achieves higher precision in cleaving at specific nucleotide sequences while maintaining reproducibility across experiments

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent employs controlled digestion time and temperature conditions to dynamically regulate enzyme activity. By optimizing the duration and thermal conditions of the reaction, the method achieves complete yet specific cleavage, preventing both under-digestion and non-specific degradation

Inventive Principle:
Principle #15Dynamics

2Loss of information

If limited digestion is performed to preserve location-specific information, then sequence information is maintained, but complete sequence coverage is difficult to achieve

Engineering Contradiction:
Improvelocation-specific information retentionVSAvoidsequence coverage completeness
Core Design Contradiction:
Loss of informationVSProductivity

Solution Approach 1:

The patent applies controlled partial digestion by limiting the reaction time and enzyme concentration, allowing cleavage at high-affinity specific sites while avoiding degradation at lower-affinity sites. This partial action strategy preserves location-specific information while achieving sufficient sequence coverage for mapping

Inventive Principle:
Principle #16Partial or excessive action

Solution Approach 2:

The method generates a segmented set of oligonucleotide fragments with defined length distributions through optimized digestion conditions. These segments are then separated and analyzed by LC-MS, with computational assembly reconstructing the complete sequence from the segmented pieces

Inventive Principle:
Principle #1Segmentation

3Adaptability or versatility

If T2 family endoribonucleases are used under suboptimal conditions, then some nucleotide preference is exhibited, but specificity is poorly defined and LC-MS peak identification is cumbersome

Engineering Contradiction:
Improvenucleotide preference flexibilityVSAvoidcleavage specificity definition
Core Design Contradiction:
Adaptability or versatilityVSMeasurement precision

Solution Approach 1:

The patent systematically optimizes pH (6.5-9.5) and buffer composition parameters to define the nucleotide preference spectrum of T2 family endoribonucleases. Under these optimized conditions, the enzymes exhibit well-defined specificity for particular nucleotide sequences, enabling confident peak identification in LC-MS analysis

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The optimized conditions improve site-specific cleavage by 5-1000% and increase unique RNA polynucleotide production by 5-1000%, enhancing the reproducibility and confidence of RNA sequence mapping using LC-MS analysis.

Implementation Method 1

Enzymatic cleavage of RNA can be used to characterize the sequence of RNA polynucleotides. Complete hydrolysis of RNA leads to loss of location-specific information of nitrogenous bases. Therefore, limited digestion is typically performed to partially break down RNA

Methodology Applied
Scientific EffectHydrolysis: Hydrolysis

Implementation Method 2

Optimizing the pH conditions (6.5-9.5) and using ethylenediaminetetraacetic acid (EDTA) concentrations to enhance the site-specific cleavage of RNA polynucleotides with T2 family endoribonucleases

Methodology Applied
Scientific EffectChelation:

Data Source

PatentUS20260071268A1Methods of inducing site-specific cleavage of RNA polynucleotides with t2 family ribonucleases
Publication Date: 2026.03.12 WATERS TECHNOLOGY CORP
  • US20260071268A1 patent drawing
  • US20260071268A1 patent drawing
  • US20260071268A1 patent drawing

AI summary

Disclosed herein are methods that provide optimal conditions for site-specific digestion and mapping of the sequence of RNA polynucleotides using T2 family endoribonucleases, such as RNase MC1 and Cusativin.